By-Health signed the Strategic Collaboration for Innovation with DuPont, focusing on the research and application of probiotics

On September 27, 2019, By-Health Co., Ltd. (hereinafter referred to as "By-Health") signed the Strategic Collaboration for Innovation with DuPont Nutrition Biosesciences ApS (hereinafter referred to as "DuPont"). The two sides will spare concerted efforts to the scientific R&D and marketing application with probiotics as the key.

Based on the Cooperation Agreement on Innovative Strategies, the cooperation between By-Health and DuPont mainly cover: R&D of the technologies related to intestinal microecology, including Phenflex project in Europe; R&D of probiotics with potential new health claims in applications for anti-aging, skin health and oral health; and R&D and cooperation of probiotic dietary supplements in China and other innovations. 

DuPont, a wholly-owned subsidiary of U.S. Dupont Inc, aims to provide market-driven, healthy and sustainable solutions for food, beverages, dietary supplements and pharmaceutical industries with professional technologies.

Founded in October 1995, By-Health serves as a leading enterprise in dietary nutrition supplement around the world. In 2002, it took the initiative in systematically introducing the Vitamin & Dietary Supplements(VDS) into China. In 2018, it acquired multiple overseas enterprises such as Life-Space, a well-known brand of probiotics in Australia and Penta-Vite, a brand of child nutritional supplement with a history of more than 70 years owned by Bayer. Always following the global raw material strategy, By-Health has gathered high-quality raw materials around the world to produce high-quality nutrients, and continues to focus on the collaborative innovation R&D of "new functions, new materials and new technologies". 

Before the signing of this agreement, By-Health has worked closely with DuPont. DuPont's Danisco brand, as one of the largest probiotic brands around the world, is a supplier of core raw material for Life-Space probiotics. By-Health has reached an innovative strategic partnership with DuPont, and the two will carry out R&D in the mode of transnational cooperation, which may help Life-Space with the synergy of upstream and downstream industries, improve the innovation capacity of Life-Space in the R&D stage of probiotics, and further strengthen Life-Space's advantages of scientific research and product formulation in terms of probiotics.   

In the future, By-Health and Dupont will give full play to their respective strength and characteristics in scientific research, production technology, talent training, market operation and brand resources. Under the principle of resource sharing, complementary advantages, mutual benefit and common development, the two sides will carry out joint R&D in terms of microbial technology, new functional probiotics and its applications and development and registration of probiotic-related dietary supplements in China. The two sides stated that they would work hard with each other to boost the long-term development of probiotics in the Chinese market.